New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - active: allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (chenopodium album pollen extract); allergen extracts 1 ic/ml (chenopodium album pollen extract); allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts); allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - active: allergen extracts 0.1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 1 ic/ml (plantago lanceolata pollen extract); allergen extracts 1 ic/ml (plantago lanceolata pollen extract); allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - active: allergen extracts 1 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Stati Uniti - Ingliż - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - paspalum notatum pollen 10000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t